ICYMI: New Zombie Stock, Latest Accounting Standards Update, & Model Portfolio Updates
Here's what happened at New Constructs this past week.
Matt Shuler, Investment Analyst II
Matt Shuler, Investment Analyst II
Featured Stock in November’s Safest Dividend Yields Model Portfolio
Get a look at the featured Stock from November's Safest Dividend Yields Model Portfolio, which leverages our proven-superior research.
Matt Shuler, Investment Analyst II
Accounting Standards Review: December 2022
Get the scoop on ASU 2022-04 – Liabilities-Supplier Finance programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations
Kyle Guske II, Senior Investment Analyst, MBA
Zombie Stock #27 – Broker Than Broke
This company experienced a brief lift in performance as a result of the COVID pandemic, but current numbers paint a different picture.
Matt Shuler, Investment Analyst II
Dividend Growth Stocks Model Portfolio: November 2022
Platinum Members and higher can access November's Dividend Growth Stocks Model Portfolio as of Wednesday, November 30.
Kyle Guske II, Senior Investment Analyst, MBA
Focus List Stocks: Short – Update 11/30/22
We’ve made the following update to our Focus List Stocks: Short Model Portfolio as of November 30, 2022.
Kyle Guske II, Senior Investment Analyst, MBA
ICYMI: 3 More Zombie Stocks, Special Black Friday Savings, Featured Stock with Good Exec Comp, & Model Portfolio Updates
Here's what happened at New Constructs this past week.
Matt Shuler, Investment Analyst II
Zombie Stock #26 – Running Out of Resources
The company’s lack of profitability continues to destroy shareholder value.
Matt Shuler, Investment Analyst II
Zombie Stock #25 – Expectations and Reality Can’t Connect
This company's fundamentals have never been promising, and it is poised to burn even more cash going forward.
Matt Shuler, Investment Analyst II
Featured Stock in November’s Exec Comp & ROIC Model Portfolio
Get the featured stock in November’s Exec Comp Aligned with ROIC Model Portfolio.
Matt Shuler, Investment Analyst II
Safest Dividend Yields Model Portfolio: November 2022
Platinum Members and higher can access November's Safest Dividend Yields Model Portfolio as of Tuesday, November 22.
Kyle Guske II, Senior Investment Analyst, MBA
Focus List Stocks: Short – Update 11/22/22
We’ve made the following update to our Focus List Stocks: Short Model Portfolio as of November 22, 2022.
Kyle Guske II, Senior Investment Analyst, MBA
Zombie Stock #24 – Burning Cash Until the Cows Come Home
This Zombie has earned an Unattractive Rating since its IPO and has never generated a positive NOPAT or FCF.
Kyle Guske II, Senior Investment Analyst, MBA
Podcast: Why This Consumer Food Provider’s Stock Is in The Danger Zone
CEO David Trainer sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: Zombie Stock #24 – Burning Cash Until the Cows Come Home.
Kyle Guske II, Senior Investment Analyst, MBA
ICYMI: 4 New Zombie Stocks, Model Portfolio Performances Thru 3Q22, Our Mutual Fund & ETF Warnings Save You $, & Model Portfolio Updates
Here's what happened at New Constructs this past week.
Matt Shuler, Investment Analyst II
Why You Should Avoid ETFs in the Danger Zone
Heeding these ETF warnings can protect your portfolio from blowups and help you outperform.
Kyle Guske II, Senior Investment Analyst, MBA
Why You Should Avoid Mutual Funds In the Danger Zone
Heeding these mutual fund warnings can protect your portfolio from blowups and help you outperform.
Kyle Guske II, Senior Investment Analyst, MBA
Zombie Stock #23 – Access Denied
No matter how you analyze its business, one thing is clear: this company burns through a large amount of cash.
Matt Shuler, Investment Analyst II
Zombie Stock #22 – No One to Pay the Bills
This Zombie's profitability has been weakening since 2018.
Matt Shuler, Investment Analyst II
Zombie Stock #21 – Don’t Join This Team
This company will need either a capital raise or a significant change in business operations soon to remain a going concern.
Matt Shuler, Investment Analyst II